Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Advancing virtual primary care for people with opioid use disorder (VPC OUD): a mixed-methods study protocol.
Hedden L, McCracken RK, Spencer S, Narayan S, Gooderham E, Bach P, Boyd J, Chakanyuka C, Hayashi K, Klimas J, Law M, McGrail K, Nosyk B, Peterson S, Sutherland C, Ti L, Yung S, Cameron F, Fernandez R, Giesler A, Strydom N. Hedden L, et al. Among authors: giesler a. BMJ Open. 2022 Sep 26;12(9):e067608. doi: 10.1136/bmjopen-2022-067608. BMJ Open. 2022. PMID: 36167365 Free PMC article.
Minimally Invasive Real-Time Detection of Actionable Mutations in Patients With Metastatic Solid Tumors Using Fine-Needle and Liquid Biopsies.
Aung KL, Bedard PL, Yu C, Boerner SL, Zuzarte PC, Ghai S, Berman HK, Serra S, Giesler A, Ahmed L, Joshua AM, Moore MJ, Oza AM, Amir E, McPherson JD, Zhang T, Sukhai MA, Stockley TL, Kamel-Reid S, Siu LL, Hansen AR. Aung KL, et al. Among authors: giesler a. JCO Precis Oncol. 2018 Nov;2:1-20. doi: 10.1200/PO.17.00248. JCO Precis Oncol. 2018. PMID: 35135130
Predicting Toxicity and Response to Pembrolizumab Through Germline Genomic HLA Class 1 Analysis.
Iafolla MAJ, Yang C, Chandran V, Pintilie M, Li Q, Bedard PL, Hansen A, Lheureux S, Spreafico A, Razak AA, Hakgor S, Giesler A, Pugh TJ, Siu LL. Iafolla MAJ, et al. Among authors: giesler a. JNCI Cancer Spectr. 2020 Dec 29;5(1):pkaa115. doi: 10.1093/jncics/pkaa115. eCollection 2021 Feb. JNCI Cancer Spectr. 2020. PMID: 33554038 Free PMC article. Clinical Trial.
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE).
Clouthier DL, Lien SC, Yang SYC, Nguyen LT, Manem VSK, Gray D, Ryczko M, Razak ARA, Lewin J, Lheureux S, Colombo I, Bedard PL, Cescon D, Spreafico A, Butler MO, Hansen AR, Jang RW, Ghai S, Weinreb I, Sotov V, Gadalla R, Noamani B, Guo M, Elston S, Giesler A, Hakgor S, Jiang H, McGaha T, Brooks DG, Haibe-Kains B, Pugh TJ, Ohashi PS, Siu LL. Clouthier DL, et al. Among authors: giesler a. J Immunother Cancer. 2019 Mar 13;7(1):72. doi: 10.1186/s40425-019-0541-0. J Immunother Cancer. 2019. PMID: 30867072 Free PMC article. Clinical Trial.
Latency and interval therapy affect the evolution in metastatic colorectal cancer.
Nikbakht H, Jessa S, Sukhai MA, Arseneault M, Zhang T, Letourneau L, Thomas M, Bourgey M, Roehrl MHA, Eveleigh R, Chen EX, Krzyzanowska M, Moore MJ, Giesler A, Yu C, Bedard PL, Kamel-Reid S, Majewski J, Siu LL, Riazalhosseini Y, Graham DM. Nikbakht H, et al. Among authors: giesler a. Sci Rep. 2020 Jan 17;10(1):581. doi: 10.1038/s41598-020-57476-y. Sci Rep. 2020. PMID: 31953485 Free PMC article.
20 results